Quick Answer
AIM ImmunoTech Inc. reported Total Assets of $5.78 million for fiscal year 2025.
AIM ImmunoTech Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $5.78M | -32.8% |
| 2024 | $8.61M | -55.6% |
| 2023 | $19.38M | -52.1% |
| 2022 | $40.49M | -29.8% |
| 2021 | $57.70M | -10.7% |
| 2020 | $64.58M | +211.2% |
| 2019 | $20.75M | +49.9% |
| 2018 | $13.85M | -2.5% |
| 2017 | $14.21M | -24.7% |
| 2016 | $18.87M | -17.2% |
| 2015 | $22.80M | -22.5% |
| 2014 | $29.44M | -7.6% |
| 2013 | $31.87M | -44.8% |
| 2012 | $57.70M | +32.6% |
| 2011 | $43.51M | -15.8% |
| 2010 | $51.68M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.49M | -59.6% | +33.1% |
| June 30, 2025 | $4.13M | -73.7% | -33.9% |
| March 31, 2025 | $6.25M | -61.4% | -27.4% |
| December 31, 2024 | $8.61M | -55.6% | -36.6% |
| September 30, 2024 | $13.59M | -51.2% | -13.5% |
| June 30, 2024 | $15.71M | -53.3% | -2.9% |
| March 31, 2024 | $16.19M | -56.8% | -16.5% |
| December 31, 2023 | $19.38M | -52.1% | -30.4% |
- AIM ImmunoTech Inc. showed a decrease of -32.8% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, AIM ImmunoTech Inc.’s total assets has declined by 88.8% (from $51.68 million to $5.78 million).
- The most recent figure is from AIM ImmunoTech Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: